Human Gene MIR101-1 (uc001dbx.3)
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
FU261130 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763632 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HV304531 - JP 2009531018-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305029 - JP 2009531019-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119238 - JP 2013046612-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589567 - JP 2013121348-A/98: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413371 - JP 2014060993-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501582 - JP 2016025853-A/98: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA525948 - Sequence 98 from Patent EP2369011. JA526455 - Sequence 98 from Patent EP2369012. JA526962 - Sequence 98 from Patent EP2369013. JA535891 - Sequence 98 from Patent EP2371971. JA787896 - Sequence 98 from Patent EP2479285. JA788394 - Sequence 98 from Patent EP2479286. JA810728 - Sequence 98 from Patent EP2468890. JA811226 - Sequence 98 from Patent EP2468891. JA811724 - Sequence 98 from Patent EP2468893. JA812222 - Sequence 98 from Patent EP2468894. JA812720 - Sequence 98 from Patent EP2468895. JA813218 - Sequence 98 from Patent EP2468896. JA813716 - Sequence 98 from Patent EP2468897. JA814214 - Sequence 98 from Patent EP2468898. JA814712 - Sequence 98 from Patent EP2468899. JA816955 - Sequence 98 from Patent EP2468892. JA825767 - Sequence 98 from Patent EP2471956. JA826265 - Sequence 98 from Patent EP2471958. JB024552 - Sequence 98 from Patent EP2505668. JB025050 - Sequence 98 from Patent EP2505669. JB079437 - Sequence 98 from Patent EP2487252. JB079935 - Sequence 98 from Patent EP2487253. JB080433 - Sequence 98 from Patent EP2487254. JB080931 - Sequence 98 from Patent EP2487255. JB081429 - Sequence 98 from Patent EP2487256. JB081927 - Sequence 98 from Patent EP2487257. JB082425 - Sequence 98 from Patent EP2487258. JB082923 - Sequence 98 from Patent EP2487259. JB083421 - Sequence 98 from Patent EP2487260. JB083919 - Sequence 98 from Patent EP2487261. JB084417 - Sequence 98 from Patent EP2487262. JB084915 - Sequence 98 from Patent EP2487263. JB087593 - Sequence 98 from Patent EP2502630. JB147797 - Sequence 98 from Patent EP2484782. JB148295 - Sequence 98 from Patent EP2484783. JB153020 - Sequence 98 from Patent EP2514433. JB153518 - Sequence 98 from Patent EP2514434. JB622107 - Sequence 98 from Patent EP2586454. JB622605 - Sequence 98 from Patent EP2586455. JC001668 - Sequence 98 from Patent EP2591794. AF480539 - Homo sapiens miR-101-precursor-1 micro RNA, complete sequence. CS266378 - Sequence 70 from Patent WO2005118806. DI443403 - KR 1020140074997-A/24: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DL076540 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004190 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261132 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763634 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW421532 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HV304533 - JP 2009531018-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305031 - JP 2009531019-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119240 - JP 2013046612-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367403 - JP 2012228254-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411796 - JP 2014000079-A/70: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW505203 - JP 2014502606-A/105: MELANOMA TREATMENTS. HW589569 - JP 2013121348-A/100: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674142 - JP 2014217381-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW807729 - JP 2014534810-A/24: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HZ043284 - JP 2015510401-A/374: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ067084 - JP 2014012020-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ081910 - JP 2015514392-A/374: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ408246 - JP 2015528002-A/843: CHIRAL CONTROL. HZ413373 - JP 2014060993-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427508 - JP 2014217384-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428311 - JP 2014217385-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429114 - JP 2014217386-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429917 - JP 2014217387-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501584 - JP 2016025853-A/100: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769174 - JP 2014223080-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058568 - Sequence 70 from Patent EP2298893. JA059371 - Sequence 70 from Patent EP2298894. JA073694 - Sequence 70 from Patent EP2281887. JA104831 - Sequence 70 from Patent EP2302051. JA106171 - Sequence 70 from Patent EP2302052. JA106974 - Sequence 70 from Patent EP2302053. JA107777 - Sequence 70 from Patent EP2302054. JA108580 - Sequence 70 from Patent EP2302055. JA109383 - Sequence 70 from Patent EP2302056. JA191899 - Sequence 70 from Patent EP2290066. JA192798 - Sequence 70 from Patent EP2290067. JA193697 - Sequence 70 from Patent EP2290068. JA194596 - Sequence 70 from Patent EP2290069. JA195495 - Sequence 70 from Patent EP2290070. JA196394 - Sequence 70 from Patent EP2290071. JA197293 - Sequence 70 from Patent EP2290072. JA198192 - Sequence 70 from Patent EP2290073. JA199091 - Sequence 70 from Patent EP2290074. JA199990 - Sequence 70 from Patent EP2290075. JA200889 - Sequence 70 from Patent EP2290076. JA218011 - Sequence 70 from Patent EP2281888. JA226162 - Sequence 70 from Patent EP2292755. JA229017 - Sequence 70 from Patent EP2292756. JA257288 - Sequence 70 from Patent EP2284265. JA278568 - Sequence 70 from Patent EP2281886. JA284454 - Sequence 70 from Patent EP2281889. JA292507 - Sequence 70 from Patent EP2287303. JA317693 - Sequence 70 from Patent EP2314688. JA374752 - Sequence 70 from Patent EP2322616. JA525950 - Sequence 100 from Patent EP2369011. JA526457 - Sequence 100 from Patent EP2369012. JA526964 - Sequence 100 from Patent EP2369013. JA535893 - Sequence 100 from Patent EP2371971. JA787898 - Sequence 100 from Patent EP2479285. JA788396 - Sequence 100 from Patent EP2479286. JA810730 - Sequence 100 from Patent EP2468890. JA811228 - Sequence 100 from Patent EP2468891. JA811726 - Sequence 100 from Patent EP2468893. JA812224 - Sequence 100 from Patent EP2468894. JA812722 - Sequence 100 from Patent EP2468895. JA813220 - Sequence 100 from Patent EP2468896. JA813718 - Sequence 100 from Patent EP2468897. JA814216 - Sequence 100 from Patent EP2468898. JA814714 - Sequence 100 from Patent EP2468899. JA816957 - Sequence 100 from Patent EP2468892. JA825769 - Sequence 100 from Patent EP2471956. JA826267 - Sequence 100 from Patent EP2471958. JB024554 - Sequence 100 from Patent EP2505668. JB025052 - Sequence 100 from Patent EP2505669. JB037931 - Sequence 47 from Patent WO2012107841. JB079439 - Sequence 100 from Patent EP2487252. JB079937 - Sequence 100 from Patent EP2487253. JB080435 - Sequence 100 from Patent EP2487254. JB080933 - Sequence 100 from Patent EP2487255. JB081431 - Sequence 100 from Patent EP2487256. JB081929 - Sequence 100 from Patent EP2487257. JB082427 - Sequence 100 from Patent EP2487258. JB082925 - Sequence 100 from Patent EP2487259. JB083423 - Sequence 100 from Patent EP2487260. JB083921 - Sequence 100 from Patent EP2487261. JB084419 - Sequence 100 from Patent EP2487262. JB084917 - Sequence 100 from Patent EP2487263. JB087595 - Sequence 100 from Patent EP2502630. JB147799 - Sequence 100 from Patent EP2484782. JB148297 - Sequence 100 from Patent EP2484783. JB153022 - Sequence 100 from Patent EP2514433. JB153520 - Sequence 100 from Patent EP2514434. JB622109 - Sequence 100 from Patent EP2586454. JB622607 - Sequence 100 from Patent EP2586455. JC001670 - Sequence 100 from Patent EP2591794. JC221595 - Sequence 70 from Patent EP2471923. JC268161 - Sequence 70 from Patent EP2471924. JC340469 - Sequence 70 from Patent EP2471922. JC469715 - Sequence 70 from Patent EP2471921. JC526213 - Sequence 3 from Patent WO2014083081. JC990504 - Sequence 70 from Patent EP2808390. LF404381 - JP 2015509366-A/374: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF714607 - JP 2016165292-A/70: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856541 - JP 2015142597-A/70: METHODS AND COMPOSITIONS INVOLVING MicroRNA. LG051580 - KR 1020150036642-A/846: CHIRAL CONTROL. LQ101342 - Sequence 47 from Patent WO2015101653. LQ276057 - Sequence 47 from Patent WO2016071729. MA259150 - JP 2017502699-A/47: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA353912 - JP 2018075017-A/374: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. AF480499 - Homo sapiens microRNA miR-101 gene, complete sequence. CS166338 - Sequence 49 from Patent WO2005078096. CS265311 - Sequence 53 from Patent EP1627925. CS444366 - Sequence 53 from Patent WO2006108473. CS548248 - Sequence 1278 from Patent EP1777301. DJ003739 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DJ027018 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof. DL231883 - Method for the determination of cellular transcriptional regulation. FU261398 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU261399 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763900 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FU763901 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW311989 - DETECTING NUCLEIC ACIDS. HV304799 - JP 2009531018-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV304800 - JP 2009531018-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305297 - JP 2009531019-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV305298 - JP 2009531019-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HV954032 - JP 2012518421-A/944: METHODS OF DETECTING LUNG CANCER. HW119506 - JP 2013046612-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119507 - JP 2013046612-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW589835 - JP 2013121348-A/366: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW589836 - JP 2013121348-A/367: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HZ413639 - JP 2014060993-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ413640 - JP 2014060993-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501850 - JP 2016025853-A/366: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ501851 - JP 2016025853-A/367: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. JA526216 - Sequence 366 from Patent EP2369011. JA526217 - Sequence 367 from Patent EP2369011. JA526723 - Sequence 366 from Patent EP2369012. JA526724 - Sequence 367 from Patent EP2369012. JA527230 - Sequence 366 from Patent EP2369013. JA527231 - Sequence 367 from Patent EP2369013. JA536159 - Sequence 366 from Patent EP2371971. JA536160 - Sequence 367 from Patent EP2371971. JA715162 - Sequence 944 from Patent EP2401406. JA788164 - Sequence 366 from Patent EP2479285. JA788165 - Sequence 367 from Patent EP2479285. JA788662 - Sequence 366 from Patent EP2479286. JA788663 - Sequence 367 from Patent EP2479286. JA810996 - Sequence 366 from Patent EP2468890. JA810997 - Sequence 367 from Patent EP2468890. JA811494 - Sequence 366 from Patent EP2468891. JA811495 - Sequence 367 from Patent EP2468891. JA811992 - Sequence 366 from Patent EP2468893. JA811993 - Sequence 367 from Patent EP2468893. JA812490 - Sequence 366 from Patent EP2468894. JA812491 - Sequence 367 from Patent EP2468894. JA812988 - Sequence 366 from Patent EP2468895. JA812989 - Sequence 367 from Patent EP2468895. JA813486 - Sequence 366 from Patent EP2468896. JA813487 - Sequence 367 from Patent EP2468896. JA813984 - Sequence 366 from Patent EP2468897. JA813985 - Sequence 367 from Patent EP2468897. JA814482 - Sequence 366 from Patent EP2468898. JA814483 - Sequence 367 from Patent EP2468898. JA814980 - Sequence 366 from Patent EP2468899. JA814981 - Sequence 367 from Patent EP2468899. JA817223 - Sequence 366 from Patent EP2468892. JA817224 - Sequence 367 from Patent EP2468892. JA826035 - Sequence 366 from Patent EP2471956. JA826036 - Sequence 367 from Patent EP2471956. JA826533 - Sequence 366 from Patent EP2471958. JA826534 - Sequence 367 from Patent EP2471958. JB024820 - Sequence 366 from Patent EP2505668. JB024821 - Sequence 367 from Patent EP2505668. JB025318 - Sequence 366 from Patent EP2505669. JB025319 - Sequence 367 from Patent EP2505669. JB079705 - Sequence 366 from Patent EP2487252. JB079706 - Sequence 367 from Patent EP2487252. JB080203 - Sequence 366 from Patent EP2487253. JB080204 - Sequence 367 from Patent EP2487253. JB080701 - Sequence 366 from Patent EP2487254. JB080702 - Sequence 367 from Patent EP2487254. JB081199 - Sequence 366 from Patent EP2487255. JB081200 - Sequence 367 from Patent EP2487255. JB081697 - Sequence 366 from Patent EP2487256. JB081698 - Sequence 367 from Patent EP2487256. JB082195 - Sequence 366 from Patent EP2487257. JB082196 - Sequence 367 from Patent EP2487257. JB082693 - Sequence 366 from Patent EP2487258. JB082694 - Sequence 367 from Patent EP2487258. JB083191 - Sequence 366 from Patent EP2487259. JB083192 - Sequence 367 from Patent EP2487259. JB083689 - Sequence 366 from Patent EP2487260. JB083690 - Sequence 367 from Patent EP2487260. JB084187 - Sequence 366 from Patent EP2487261. JB084188 - Sequence 367 from Patent EP2487261. JB084685 - Sequence 366 from Patent EP2487262. JB084686 - Sequence 367 from Patent EP2487262. JB085183 - Sequence 366 from Patent EP2487263. JB085184 - Sequence 367 from Patent EP2487263. JB087861 - Sequence 366 from Patent EP2502630. JB087862 - Sequence 367 from Patent EP2502630. JB148065 - Sequence 366 from Patent EP2484782. JB148066 - Sequence 367 from Patent EP2484782. JB148563 - Sequence 366 from Patent EP2484783. JB148564 - Sequence 367 from Patent EP2484783. JB153288 - Sequence 366 from Patent EP2514433. JB153289 - Sequence 367 from Patent EP2514433. JB153786 - Sequence 366 from Patent EP2514434. JB153787 - Sequence 367 from Patent EP2514434. JB622375 - Sequence 366 from Patent EP2586454. JB622376 - Sequence 367 from Patent EP2586454. JB622873 - Sequence 366 from Patent EP2586455. JB622874 - Sequence 367 from Patent EP2586455. JC001936 - Sequence 366 from Patent EP2591794. JC001937 - Sequence 367 from Patent EP2591794. JC334093 - Sequence 11 from Patent EP2487240. LP636956 - Sequence 6 from Patent EP2848702. DI443401 - KR 1020140074997-A/22: MICRORNAS IN NEURODEGENERATIVE DISORDERS. DI443402 - KR 1020140074997-A/23: MICRORNAS IN NEURODEGENERATIVE DISORDERS. FW363959 - Oligonucleotides for modulating target RNA activity. FW371680 - Human-derived nuclear acids for inhibiting HIV protein expression. FW371723 - Human-derived nuclear acids for inhibiting HIV protein expression. FW371749 - Human-derived nuclear acids for inhibiting HIV protein expression. FZ414237 - WO 2011007815-A/127: A method for screening a food which promotes production of milk having immunoregulating effect. HI965598 - Sequence 883 from Patent WO2010139812. HI965878 - Sequence 198 from Patent WO2010139811. HI966744 - Sequence 198 from Patent WO2010139810. HV335765 - JP 2011093892-A/8: Tumor proliferation suppressor comprising tumor suppressive micro RNA. HV540980 - WO 2011125469-A/24: A recombinant vaccinia virus regulated by miRNA and use thereof. HV543892 - JP 2011217617-A/3: Method for testing fibrosis of chronic liver diseases using miRNAs. HV593806 - JP 2010538610-A/19: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. HV594735 - JP 2010539959-A/116: Micromirs. HV821765 - JP 2011140513-A/127: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition. HW060363 - JP 2012527478-A/27: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure. HW248820 - JP 2013514372-A/19: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY. HW289768 - JP 2013520158-A/11: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HW505392 - JP 2014502606-A/294: MELANOMA TREATMENTS. HW505393 - JP 2014502606-A/295: MELANOMA TREATMENTS. HW523272 - JP 2014507123-A/57: BLOOD-BORNE MIRNAS AS SURROGATE MARKERS OF DRUG EFFICACY FOR CARDIAC CONDITIONS. HW807727 - JP 2014534810-A/22: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HW807728 - JP 2014534810-A/23: MICRORNAS IN NEURODEGENERATIVE DISORDERS. HW913302 - JP 2015504307-A/62: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS. HZ043173 - JP 2015510401-A/263: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ043364 - JP 2015510401-A/454: MESENCHYMAL STEM CELLS FOR IN VITRO MODELING AND CELL-BASED THERAPY OF HUMAN DISEASES AND BANKS THEREOF. HZ073982 - JP 2013535982-A/73: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ081799 - JP 2015514392-A/263: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ081990 - JP 2015514392-A/454: MicroRNAS FOR THE GENERATION OF ASTROCYTES. HZ082785 - JP 2015513906-A/142: Stem Cell Microparticles. HZ157292 - JP 2015130862-A/116: Micromirs. HZ186272 - JP 2015146814-A/21: Oligonucleotides for modulating target RNA activity. HZ392505 - JP 2015180203-A/11: REENGINEERING MRNA PRIMARY STRUCTURE FOR ENHANCED PROTEIN PRODUCTION. HZ436566 - JP 2015529450-A/142: Stem Cell Microparticles. HZ479612 - JP 2015535430-A/118: TERMINALLY MODIFIED RNA. HZ789543 - JP 2016504050-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA401636 - Sequence 883 from Patent WO2011080318. JA402614 - Sequence 883 from Patent WO2011080315. JA403621 - Sequence 883 from Patent WO2011080316. JA406252 - Sequence 883 from Patent EP2336353. JA429778 - Sequence 883 from Patent WO2011095623. JA660711 - Sequence 165 from Patent WO2011131354. JA667974 - Sequence 53 from Patent WO2011139911. JA682599 - Sequence 67 from Patent WO2011149354. JA781908 - Sequence 19 from Patent EP2513307. JA791704 - Sequence 106 from Patent WO2012089772. JA792209 - Sequence 258 from Patent WO2012089753. JA885427 - Sequence 57 from Patent WO2012083004. JB022216 - Sequence 58 from Patent WO2013026685. JB037933 - Sequence 49 from Patent WO2012107841. JB037935 - Sequence 51 from Patent WO2012107841. JB049969 - Sequence 56 from Patent WO2013020926. JB075014 - Sequence 274 from Patent WO2012168448. JB149052 - Sequence 127 from Patent EP2455486. JB174975 - Sequence 7 from Patent WO2012101219. JB233495 - Sequence 27 from Patent EP2437750. JB406720 - Sequence 46 from Patent WO2012072685. JB620157 - Sequence 137 from Patent WO2013063544. JB778683 - Sequence 62 from Patent WO2013078283. JC171770 - Sequence 142 from Patent WO2013150303. JC244460 - Sequence 80 from Patent WO2012020308. JC505991 - Sequence 10 from Patent EP2733219. JC512275 - Sequence 2528 from Patent WO2014113089. JC572581 - Sequence 142 from Patent WO2014125276. JC582269 - Sequence 142 from Patent WO2014125277. JC737415 - Sequence 10 from Patent WO2014075911. JE869373 - Sequence 14 from Patent WO2015131115. JE953965 - Sequence 142 from Patent WO2015052526. JE955718 - Sequence 142 from Patent WO2015052527. JE978720 - Sequence 165 from Patent EP2865765. LF137470 - JP 2016507550-A/142: Method of Producing Microparticles. LF161151 - JP 2016513950-A/1217: Oligomers with improved off-target profile. LF162435 - JP 2016513095-A/142: Stem Cell Microparticles and miRNA. LF404270 - JP 2015509366-A/263: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. LF636233 - JP 2016519076-A/7: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS. LF857570 - JP 2015130879-A/19: MICRORNA SIGNATURES IN HUMAN OVARIAN CANCER. LF953187 - JP 2016534103-A/142: Stem Cell Microparticles and miRNA. LG005532 - KR 1020150004822-A/142: STEM CELL MICROPARTICLES. LG053228 - KR 1020150059168-A/142: STEM CELL MICROPARTICLES. LG134390 - KR 1020150131312-A/7: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS. LG240467 - KR 1020160035087-A/142: STEM CELL MICROPARTICLES AND MIRNA. LP726504 - Sequence 198 from Patent EP2883966. LP769606 - Sequence 133 from Patent EP3294910. LP782001 - Sequence 6 from Patent WO2018055093. LP818774 - Sequence 198 from Patent EP3296406. LP835272 - Sequence 70 from Patent WO2017108535. LP896626 - Sequence 1490 from Patent EP3253886. LP938716 - Sequence 198 from Patent EP3184651. LP939579 - Sequence 70 from Patent EP3184646. LP951523 - Sequence 29 from Patent WO2017157650. LQ069863 - Sequence 187 from Patent EP2964234. LQ101344 - Sequence 49 from Patent WO2015101653. LQ101346 - Sequence 51 from Patent WO2015101653. LQ276059 - Sequence 49 from Patent WO2016071729. LQ276061 - Sequence 51 from Patent WO2016071729. LQ278646 - Sequence 185 from Patent WO2016066288. LQ441267 - Sequence 274 from Patent EP3029157. LQ500605 - Sequence 19 from Patent EP3048177. LQ664820 - Sequence 9 from Patent WO2016150475. LV470552 - JP 2016534036-A/142: Stem Cell Microparticles and miRNA. LY404800 - KR 1020160117535-A/105: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY409569 - KR 1020160122850-A/14: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. LY504616 - KR 1020170035932-A/5: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ233629 - JP 2017184756-A/21: Oligonucleotides for modulating target RNA activity. LZ242897 - JP 2017525350-A/5: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. MA259152 - JP 2017502699-A/49: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA259154 - JP 2017502699-A/51: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA260039 - JP 2017505623-A/105: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA264551 - JP 2017507955-A/14: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER. MA353801 - JP 2018075017-A/263: GENERATION OF NEURAL STEM CELLS AND MOTOR NEURONS. MS834737 - Sequence 883 from Patent EP3112479. MS901585 - Sequence 58 from Patent EP3156505. MS904103 - Sequence 19 from Patent EP3138926. MS944749 - Sequence 5 from Patent EP3177739. MS946561 - Sequence 7 from Patent WO2017037477. CQ873632 - Sequence 51 from Patent WO2004076622. DD413469 - Regulation of Mammalian Cells. CS266569 - Sequence 261 from Patent WO2005118806. DL076731 - METHODS AND COMPOSITIONS INVOLVING MicroRNA. DM004381 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. FU261131 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS. FU763633 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. FW421723 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HV304532 - JP 2009531018-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER. HV305030 - JP 2009531019-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW119239 - JP 2013046612-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HW367594 - JP 2012228254-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HW411987 - JP 2014000079-A/261: METHODS AND COMPOSITIONS INVOLVING MicroRNA. HW589568 - JP 2013121348-A/99: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS. HW674333 - JP 2014217381-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ067275 - JP 2014012020-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ413372 - JP 2014060993-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ427699 - JP 2014217384-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ428502 - JP 2014217385-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ429305 - JP 2014217386-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ430108 - JP 2014217387-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. HZ501583 - JP 2016025853-A/99: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS. HZ769365 - JP 2014223080-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. JA058759 - Sequence 261 from Patent EP2298893. JA059562 - Sequence 261 from Patent EP2298894. JA073885 - Sequence 261 from Patent EP2281887. JA105022 - Sequence 261 from Patent EP2302051. JA106362 - Sequence 261 from Patent EP2302052. JA107165 - Sequence 261 from Patent EP2302053. JA107968 - Sequence 261 from Patent EP2302054. JA108771 - Sequence 261 from Patent EP2302055. JA109574 - Sequence 261 from Patent EP2302056. JA192090 - Sequence 261 from Patent EP2290066. JA192989 - Sequence 261 from Patent EP2290067. JA193888 - Sequence 261 from Patent EP2290068. JA194787 - Sequence 261 from Patent EP2290069. JA195686 - Sequence 261 from Patent EP2290070. JA196585 - Sequence 261 from Patent EP2290071. JA197484 - Sequence 261 from Patent EP2290072. JA198383 - Sequence 261 from Patent EP2290073. JA199282 - Sequence 261 from Patent EP2290074. JA200181 - Sequence 261 from Patent EP2290075. JA201080 - Sequence 261 from Patent EP2290076. JA218202 - Sequence 261 from Patent EP2281888. JA226353 - Sequence 261 from Patent EP2292755. JA229208 - Sequence 261 from Patent EP2292756. JA257479 - Sequence 261 from Patent EP2284265. JA278759 - Sequence 261 from Patent EP2281886. JA284645 - Sequence 261 from Patent EP2281889. JA292698 - Sequence 261 from Patent EP2287303. JA317884 - Sequence 261 from Patent EP2314688. JA374943 - Sequence 261 from Patent EP2322616. JA525949 - Sequence 99 from Patent EP2369011. JA526456 - Sequence 99 from Patent EP2369012. JA526963 - Sequence 99 from Patent EP2369013. JA535892 - Sequence 99 from Patent EP2371971. JA787897 - Sequence 99 from Patent EP2479285. JA788395 - Sequence 99 from Patent EP2479286. JA810729 - Sequence 99 from Patent EP2468890. JA811227 - Sequence 99 from Patent EP2468891. JA811725 - Sequence 99 from Patent EP2468893. JA812223 - Sequence 99 from Patent EP2468894. JA812721 - Sequence 99 from Patent EP2468895. JA813219 - Sequence 99 from Patent EP2468896. JA813717 - Sequence 99 from Patent EP2468897. JA814215 - Sequence 99 from Patent EP2468898. JA814713 - Sequence 99 from Patent EP2468899. JA816956 - Sequence 99 from Patent EP2468892. JA825768 - Sequence 99 from Patent EP2471956. JA826266 - Sequence 99 from Patent EP2471958. JB024553 - Sequence 99 from Patent EP2505668. JB025051 - Sequence 99 from Patent EP2505669. JB079438 - Sequence 99 from Patent EP2487252. JB079936 - Sequence 99 from Patent EP2487253. JB080434 - Sequence 99 from Patent EP2487254. JB080932 - Sequence 99 from Patent EP2487255. JB081430 - Sequence 99 from Patent EP2487256. JB081928 - Sequence 99 from Patent EP2487257. JB082426 - Sequence 99 from Patent EP2487258. JB082924 - Sequence 99 from Patent EP2487259. JB083422 - Sequence 99 from Patent EP2487260. JB083920 - Sequence 99 from Patent EP2487261. JB084418 - Sequence 99 from Patent EP2487262. JB084916 - Sequence 99 from Patent EP2487263. JB087594 - Sequence 99 from Patent EP2502630. JB147798 - Sequence 99 from Patent EP2484782. JB148296 - Sequence 99 from Patent EP2484783. JB153021 - Sequence 99 from Patent EP2514433. JB153519 - Sequence 99 from Patent EP2514434. JB622108 - Sequence 99 from Patent EP2586454. JB622606 - Sequence 99 from Patent EP2586455. JC001669 - Sequence 99 from Patent EP2591794. JC221786 - Sequence 261 from Patent EP2471923. JC268352 - Sequence 261 from Patent EP2471924. JC340660 - Sequence 261 from Patent EP2471922. JC469906 - Sequence 261 from Patent EP2471921. JC990695 - Sequence 261 from Patent EP2808390. LF714798 - JP 2016165292-A/261: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES. LF856732 - JP 2015142597-A/261: METHODS AND COMPOSITIONS INVOLVING MicroRNA. FW363960 - Oligonucleotides for modulating target RNA activity. HI965597 - Sequence 882 from Patent WO2010139812. HI966161 - Sequence 481 from Patent WO2010139811. HI967027 - Sequence 481 from Patent WO2010139810. HV594736 - JP 2010539959-A/117: Micromirs. HW505550 - JP 2014502606-A/452: MELANOMA TREATMENTS. HZ073981 - JP 2013535982-A/72: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ157293 - JP 2015130862-A/117: Micromirs. HZ186273 - JP 2015146814-A/22: Oligonucleotides for modulating target RNA activity. HZ479613 - JP 2015535430-A/119: TERMINALLY MODIFIED RNA. HZ789544 - JP 2016504050-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA293244 - Sequence 2 from Patent WO2011014083. JA401635 - Sequence 882 from Patent WO2011080318. JA402613 - Sequence 882 from Patent WO2011080315. JA403620 - Sequence 882 from Patent WO2011080316. JA406251 - Sequence 882 from Patent EP2336353. JA427039 - Sequence 372 from Patent WO2011072177. JA429777 - Sequence 882 from Patent WO2011095623. JA757932 - Sequence 65 from Patent WO2012010584. JB022576 - Sequence 418 from Patent WO2013026685. JB037932 - Sequence 48 from Patent WO2012107841. JB620156 - Sequence 136 from Patent WO2013063544. JB770412 - Sequence 39 from Patent EP2604690. JC008840 - Sequence 39 from Patent WO2013088338. JC244459 - Sequence 79 from Patent WO2012020308. JC512276 - Sequence 2529 from Patent WO2014113089. JC964004 - Sequence 39 from Patent EP2816114. LF160068 - JP 2016513950-A/134: Oligomers with improved off-target profile. LP726787 - Sequence 481 from Patent EP2883966. LP769478 - Sequence 5 from Patent EP3294910. LP819057 - Sequence 481 from Patent EP3296406. LP874699 - Sequence 1 from Patent WO2017102838. LP874929 - Sequence 1 from Patent WO2017102841. LP938999 - Sequence 481 from Patent EP3184651. LP951703 - Sequence 209 from Patent WO2017157650. LQ069864 - Sequence 188 from Patent EP2964234. LQ101343 - Sequence 48 from Patent WO2015101653. LQ276058 - Sequence 48 from Patent WO2016071729. LQ278565 - Sequence 104 from Patent WO2016066288. LQ425401 - Sequence 2 from Patent EP3037550. LY404801 - KR 1020160117535-A/106: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY504703 - KR 1020170035932-A/92: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. LZ233630 - JP 2017184756-A/22: Oligonucleotides for modulating target RNA activity. LZ242984 - JP 2017525350-A/92: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER. MA259151 - JP 2017502699-A/48: LUNG CANCER DETERMINATIONS USING MIRNA RATIOS. MA260040 - JP 2017505623-A/106: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MS834736 - Sequence 882 from Patent EP3112479. MS901945 - Sequence 418 from Patent EP3156505. MS944836 - Sequence 92 from Patent EP3177739. MA643364 - JP 2017113010-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731248 - JP 2017140048-A/118: TERMINALLY MODIFIED RNA. MA643365 - JP 2017113010-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA731249 - JP 2017140048-A/119: TERMINALLY MODIFIED RNA. MA400946 - JP 2018515097-A/133: Method for Diagnosis and Prognosis of Chronic Heart Failure. MA400818 - JP 2018515097-A/5: Method for Diagnosis and Prognosis of Chronic Heart Failure. LQ955688 - Sequence 19 from Patent EP2775001. MA406415 - JP 2018518147-A/45: Detection of Brain Injury. MA406380 - JP 2018518147-A/10: Detection of Brain Injury. MP045552 - Sequence 374 from Patent EP3401394. MP084222 - Sequence 374 from Patent EP3401393. MP015446 - Sequence 649 from Patent WO2019016252. MP045441 - Sequence 263 from Patent EP3401394. MP070414 - Sequence 11 from Patent WO2018231851. MP084111 - Sequence 263 from Patent EP3401393. MP084302 - Sequence 454 from Patent EP3401393. MA800417 - JP 2018183181-A/1288: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA800418 - JP 2018183181-A/1289: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MP129242 - Sequence 142 from Patent EP3470073. MP162165 - Sequence 142 from Patent WO2019069093. MP197427 - Sequence 2 from Patent EP3532638. MP264414 - Sequence 1 from Patent EP3502269. MB119544 - WO 2019117257-A/66: Method of aiding detection of breast cancer. MB119997 - WO 2019117306-A/19: Method of aiding detection of Alzheimer's disease. MB119507 - WO 2019117257-A/29: Method of aiding detection of breast cancer. MB121672 - JP 2019512489-A/36: MICRORNAS AND METHODS OF THEIR USE. MB119792 - WO 2019117269-A/32: Method of aiding detection of pancreas cancer. MB119545 - WO 2019117257-A/67: Method of aiding detection of breast cancer. MB119543 - WO 2019117257-A/65: Method of aiding detection of breast cancer. MB121671 - JP 2019512489-A/35: MICRORNAS AND METHODS OF THEIR USE. MB469715 - JP 2019165701-A/2: Method for testing obtaining resistance against hormone therapy for breast cancer and kit. MP394956 - Sequence 54 from Patent EP3565903.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_029516 UCSC ID: uc001dbx.3 RefSeq Accession: NR_029516
| |
|
|
Gene Model Information
|
|
category:
| noncoding
| nonsense-mediated-decay:
| no
| RNA accession:
| NR_029516.1
|
exon count:
| 1 | CDS single in 3' UTR:
| no
| RNA size:
| 75 |
ORF size:
| 0 | CDS single in intron:
| no
| Alignment % ID:
| 100.00 |
txCdsPredict score:
| 178.00 | frame shift in genome:
| no
| % Coverage:
| 100.00 |
has start codon:
| no
| stop codon in genome:
| no
| # of Alignments:
| 1 |
has end codon:
| no
| retained intron:
| no
| # AT/AC introns
| 0 |
selenocysteine:
| no
| end bleed into intron:
| 0 | # strange splices:
| 0 |
|
Click here
for a detailed description of the fields of the table above.
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|